ATE234829T1 - Verfahren zu herstellung von enantiomerisch- anreicherte tetrahydrobenzothiepin oxyden - Google Patents

Verfahren zu herstellung von enantiomerisch- anreicherte tetrahydrobenzothiepin oxyden

Info

Publication number
ATE234829T1
ATE234829T1 AT98962044T AT98962044T ATE234829T1 AT E234829 T1 ATE234829 T1 AT E234829T1 AT 98962044 T AT98962044 T AT 98962044T AT 98962044 T AT98962044 T AT 98962044T AT E234829 T1 ATE234829 T1 AT E234829T1
Authority
AT
Austria
Prior art keywords
enantiomerically enriched
oxyde
producing enantiomerically
enriched tetrahydrobenzothiepine
tetrahydrobenzothiepine
Prior art date
Application number
AT98962044T
Other languages
English (en)
Inventor
James Li
Ching-Cheng Wang
David B Reitz
Victor Snieckus
Horng-Chih Huang
Andrew J Carpenter
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Application granted granted Critical
Publication of ATE234829T1 publication Critical patent/ATE234829T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D337/00Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02Seven-membered rings
    • C07D337/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/08Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AT98962044T 1997-12-19 1998-12-16 Verfahren zu herstellung von enantiomerisch- anreicherte tetrahydrobenzothiepin oxyden ATE234829T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6817097P 1997-12-19 1997-12-19
PCT/US1998/026216 WO1999032478A1 (en) 1997-12-19 1998-12-16 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides

Publications (1)

Publication Number Publication Date
ATE234829T1 true ATE234829T1 (de) 2003-04-15

Family

ID=22080853

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98962044T ATE234829T1 (de) 1997-12-19 1998-12-16 Verfahren zu herstellung von enantiomerisch- anreicherte tetrahydrobenzothiepin oxyden

Country Status (18)

Country Link
US (2) US6369220B1 (de)
EP (1) EP1042314B1 (de)
JP (1) JP2001526284A (de)
KR (1) KR20010015884A (de)
CN (2) CN1106395C (de)
AT (1) ATE234829T1 (de)
AU (1) AU1721399A (de)
BR (1) BR9814300A (de)
DE (1) DE69812419T2 (de)
DK (1) DK1042314T3 (de)
ES (1) ES2195428T3 (de)
HU (1) HUP0101193A3 (de)
IL (1) IL136864A (de)
PT (1) PT1042314E (de)
RU (1) RU2236406C2 (de)
UA (1) UA67764C2 (de)
WO (1) WO1999032478A1 (de)
ZA (1) ZA9811648B (de)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262277B1 (en) 1994-09-13 2001-07-17 G.D. Searle And Company Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US5994391A (en) * 1994-09-13 1999-11-30 G.D. Searle And Company Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
US6221897B1 (en) * 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DK1140184T3 (da) 1998-12-23 2003-09-29 Searle Llc Kombinationer af cholesterylestertransferproteinhæmmere og nikotinsyrederivater til hjertekar indikationer
EP1286984A2 (de) 2000-03-10 2003-03-05 Pharmacia Corporation Verfahren zur herstellung von tetrahydrobenzothiepinen
EG26979A (en) 2000-12-21 2015-03-01 Astrazeneca Ab Chemical compounds
GB0121337D0 (en) 2001-09-04 2001-10-24 Astrazeneca Ab Chemical compounds
GB0121621D0 (en) 2001-09-07 2001-10-31 Astrazeneca Ab Chemical compounds
GB0121622D0 (en) 2001-09-07 2001-10-31 Astrazeneca Ab Chemical compounds
PL216023B1 (pl) 2001-09-08 2014-02-28 Astrazeneca Ab Pochodna benzotiadiazepiny, kompozycja farmaceutyczna zawierajaca pochodna benzotiadiazepiny oraz zastosowania pochodnej benzotiadiazepiny
US6740663B2 (en) * 2001-11-02 2004-05-25 G.D. Searle, Llc Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
AU2003207431A1 (en) 2002-01-17 2003-09-02 Pharmacia Corporation Novel alkyl/aryl hydroxy or keto thiepines.
GB0209467D0 (en) 2002-04-25 2002-06-05 Astrazeneca Ab Chemical compounds
GB0213669D0 (en) 2002-06-14 2002-07-24 Astrazeneca Ab Chemical compounds
GB0304194D0 (en) 2003-02-25 2003-03-26 Astrazeneca Ab Chemical compounds
GB0307918D0 (en) 2003-04-05 2003-05-14 Astrazeneca Ab Therapeutic use
KR20070026392A (ko) 2004-02-27 2007-03-08 아사히 가세이 파마 가부시키가이샤 신규 벤조티아제핀 및 벤조티에핀 화합물
EP2367554A4 (de) 2008-11-26 2020-03-25 Satiogen Pharmaceuticals, Inc. Gallensäurerückflusshemmer zur behandlung von adipositas und diabetes
EP3593802A3 (de) 2010-05-26 2020-03-25 Satiogen Pharmaceuticals, Inc. Gallensäurerückflusshemmer zur behandlung von diabetes, adipositas und entzündlichen magen-darm-erkrankungen
ES2586931T3 (es) 2010-11-04 2016-10-19 Albireo Ab Inhibidores de IBAT para el tratamiento de enfermedades hepáticas
RU2619215C2 (ru) 2010-11-08 2017-05-12 Альбирео Аб Фармацевтическая комбинация, включающая ibat-ингибитор и связующее желчной кислоты
CN102558250B (zh) * 2010-12-14 2015-01-14 王芃 一种艾杜糖醛酸及其衍生物的制备方法
KR102051031B1 (ko) 2011-10-28 2019-12-02 루메나 파마수티컬즈, 인코포레이티드 고담혈증 및 담즙 정체성 간 질환 치료용 담즙산 재순환 억제제
BR112014010223B8 (pt) 2011-10-28 2021-02-23 Lumena Pharmaceuticals Llc uso de uma composição compreendendo inibidores de reciclagem de ácido de bílis e forma de dosagem pediátrica
KR20160003664A (ko) 2013-03-15 2016-01-11 루메나 파마수티컬즈, 인코포레이티드 바렛 식도 및 위식도 역류 질환 치료용 담즙산 재순환 억제제
EP2968230A2 (de) 2013-03-15 2016-01-20 Lumena Pharmaceuticals, Inc. Gallensäurerückflusshemmer zur behandlung von primär sklerosierender cholongitis und entzündlichen darmerkrankungen
US10012627B2 (en) 2013-03-15 2018-07-03 Georgetown University Determining stereoisomeric excess, concentration and absolute configuration
JO3301B1 (ar) 2013-04-26 2018-09-16 Albireo Ab تعديلات بلورية على إيلوبيكسيبات
CN106659726A (zh) 2014-06-25 2017-05-10 Ea制药株式会社 固体制剂及其着色防止或着色减少方法
EP3012252A1 (de) 2014-10-24 2016-04-27 Ferring BV Kristalline Form von elobixibat
EP3413875B1 (de) 2016-02-09 2020-01-29 Albireo AB Cholestyraminpellets und verfahren zur herstellung davon
EP3413878B1 (de) 2016-02-09 2021-04-14 Albireo AB Orale cholestyraminformulierungen und verwendung davon
EP3413877B1 (de) 2016-02-09 2021-04-07 Albireo AB Orale cholestyraminformulierungen und verwendung davon
CN110996915B (zh) 2017-08-09 2023-10-03 阿尔比里奥公司 考来烯胺丸粒、口服考来烯胺制剂及其用途
JP2020530448A (ja) 2017-08-09 2020-10-22 アルビレオ・アクチボラグ コレスチラミン顆粒、経口コレスチラミン製剤、及びそれらの使用
JP7391048B2 (ja) 2018-06-05 2023-12-04 アルビレオ・アクチボラグ ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
MX2020013839A (es) 2018-06-20 2021-03-25 Albireo Ab Formulacion farmaceutica de odevixibat.
WO2020028396A1 (en) 2018-07-30 2020-02-06 Georgetown University Chirality sensing with molecular click chemistry probes
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
WO2020056012A1 (en) 2018-09-11 2020-03-19 Georgetown University Quantitative auxiliary-free chirality sensing with a metal probe
CN109516971B (zh) * 2018-11-26 2020-09-25 山东永浩新材料科技有限公司 一种电池级硫酸乙烯酯的合成方法
TWI835997B (zh) 2019-02-06 2024-03-21 瑞典商艾爾比瑞歐公司 苯并噻氮呯化合物及其用作膽酸調節劑之用途
RS63899B1 (sr) 2019-02-06 2023-02-28 Albireo Ab Benzotiadiazepinska jedinjenja i njihova upotreba kao modulatora žučnih kiselina
CA3129826A1 (en) 2019-02-12 2020-08-20 Mirum Pharmaceuticals, Inc. Methods for treating cholestasis
EP4069359B1 (de) 2019-12-04 2024-01-03 Albireo AB Benzothia(di)azepinverbindungen und ihre verwendung als gallensäuremodulatoren
CA3158181A1 (en) 2019-12-04 2021-06-10 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
JP7665620B2 (ja) 2019-12-04 2025-04-21 アルビレオ・アクチボラグ ベンゾチアジアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
BR112022010505A2 (pt) 2019-12-04 2022-09-06 Albireo Ab Compostos de benzotia(di)azepina e seu uso como moduladores do ácido biliar
CA3186857A1 (en) 2020-08-03 2022-02-10 Per-Goran Gillberg Benzothia(di)azepine compounds and their use as bile acid modulators
AU2021379076A1 (en) 2020-11-12 2023-06-08 Albireo Ab Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
AU2021390172A1 (en) 2020-12-04 2023-06-22 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
TW202313579A (zh) 2021-06-03 2023-04-01 瑞典商艾爾比瑞歐公司 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途
PY2373529A (es) * 2022-09-14 2024-03-25 Mirum Pharmaceuticals Inc Maralixibat formas sólidas, intermedios y procesos de hacer la misma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59144777A (ja) 1983-02-04 1984-08-18 Tokawa Tetsuo ベンゾチアゼピン誘導体の光学分割法
US5559017A (en) 1989-08-09 1996-09-24 E. R. Squibb & Sons, Inc. Microbial reduction of benzazepines and benzothiazepine derivatives
TW197435B (de) * 1990-11-22 1993-01-01 Takeda Pharm Industry Co Ltd
IT1249318B (it) 1991-05-23 1995-02-22 Zambon Spa Processo per la preparazione di benzotiazepine per ciclizzazione con acidi fosfonici
US5994391A (en) * 1994-09-13 1999-11-30 G.D. Searle And Company Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
BR9508916A (pt) * 1994-09-13 1997-12-30 Monsanto Co "Novas benzotiepinas tendo atividade como inibidores de transporte do ácido biliar ileal e absorção de taurocolato"
NZ331813A (en) 1996-03-11 2001-03-30 G Benzothiepine compounds having activity as inhibitors of ileal bile acid transport and taurocholate uptake

Also Published As

Publication number Publication date
KR20010015884A (ko) 2001-02-26
HK1034971A1 (en) 2001-11-09
ZA9811648B (en) 1999-12-20
CN1439638A (zh) 2003-09-03
BR9814300A (pt) 2002-02-05
ES2195428T3 (es) 2003-12-01
US6369220B1 (en) 2002-04-09
JP2001526284A (ja) 2001-12-18
EP1042314B1 (de) 2003-03-19
IL136864A0 (en) 2001-06-14
IL136864A (en) 2004-07-25
EP1042314A1 (de) 2000-10-11
US6875877B2 (en) 2005-04-05
PT1042314E (pt) 2003-07-31
HUP0101193A3 (en) 2001-12-28
RU2236406C2 (ru) 2004-09-20
DK1042314T3 (da) 2003-07-14
DE69812419D1 (de) 2003-04-24
HUP0101193A2 (hu) 2001-08-28
AU1721399A (en) 1999-07-12
CN1284953A (zh) 2001-02-21
WO1999032478A1 (en) 1999-07-01
CN1106395C (zh) 2003-04-23
UA67764C2 (uk) 2004-07-15
US20020188119A1 (en) 2002-12-12
DE69812419T2 (de) 2003-08-14

Similar Documents

Publication Publication Date Title
DE69812419D1 (de) Verfahren zu herstellung von enantiomerisch-anreicherte tetrahydrobenzothiepin oxyden
DE69716767D1 (de) Verfahren zur herstellung von tolterodin
ATA271885A (de) Verfahren zur herstellung von neuen aromatischen heterocyclischen verbindungen
ATA100687A (de) Verfahren zur herstellung von eisen
DE3575949D1 (de) Verfahren zur herstellung von vanadiumschlacke.
ATA355384A (de) Verfahren zur herstellung von neuen oxazolidinen
DE59805764D1 (de) Verfahren zur selektiven Herstellung von racemischen ansa-Metallocenkomplexen
DE3875008D1 (de) Verfahren zur herstellung von nitrilen.
DE68903419D1 (de) Ein verfahren zur herstellung von diisopropylauphthalenen.
AT388556B (de) Stereogesteuertes verfahren zur herstellung von neuen penem-verbindungen
ATA41091A (de) Verfahren zur herstellung von beta-(d)-2',3'-didesoxyinosin
DE3762238D1 (de) Verfahren zur herstellung von n-substituierten formamiden.
DE3765129D1 (de) Verfahren zur herstellung von nitrilen.
DE69023328D1 (de) Verfahren zur herstellung von glycin.
DE3774954D1 (de) Verfahren zur herstellung von penemen.
DE3576177D1 (de) Verfahren zur herstellung von synthesefasern.
DE58903851D1 (de) Verfahren zur herstellung von n-alkylierten anilinen.
DE69502145D1 (de) Verbessertes Verfahren zur Herstellung von Iodoniumsalzen
DE3869633D1 (de) Verfahren zur herstellung von n,n-(dibenzohexatrienylen)harnstoffen.
AT387776B (de) Verfahren zur herstellung von neuem 8alphapivaloylamino-9,10-didehydro-ergolin
DE69729631D1 (de) Verfahren zur herstellung von granisetron
ATE182140T1 (de) Optisch aktive 1,4-dihydropyridinderivate sowie verfahren zu ihrer herstellung
ATA139685A (de) Verfahren zur herstellung von neuen cephalosporinverbindungen
DE69510227D1 (de) Verfahren zur herstellung von fluorierten heterozyklischen verbindungen
ATA278985A (de) Verfahren zur herstellung von cephalosporinderivaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1042314

Country of ref document: EP

REN Ceased due to non-payment of the annual fee